hgsi

What to Watch: July 16, 2012

what to watch, hgsi, gsk, hum, citigroup, humana, glaxosmithkline, human genome sciences, fnno, business, finance, trading, stock market, analysis, news

By FNNO Staff
fnnonline@gmail.com

What's In The News: April 25, 2012

wall street, wsj, gasoline, crude, reuters, facebook, fb, instagram, microsoft, nyse, msft, human genome sciences, hgsi, glaxosmithkline, gsk, bloomberg, wal-mart, wmt, mexico, united states, business, finance, investing, stock, news, trading, analysis, market

By FNNO Staff
fnnonline@gmail.com

InterMune may receive $60 per share takeover offer

acquisition, analysis, business, esbriet, financial news, glaxosmithkline, gsk, hgsi, human genome sciences, intermune, itmn, market, merger, stock, trading

Rumors are swirling that InterMune will receive a $60 per share takeover offer. Several major drug companies are looking at InterMune following the FDA approval of its lung disease drug Esbriet. Industry sources say GlaxoSmithKlin

By FNNO Staff
fnnonline@gmail.com

Health Care Sector Update: March 10th, 2011

antibody, arena, arna, benlysta, disease, drug, fda, health, healthcare, hgsi, human genome, lupus, medical, patent, patient, pharma, sciences, shares, sle, stock, therapy, trade, treatment

Health care shares are down in mid-day trading, but Human Genome Sciences (HGSI) bucks the trend, after getting a key approval from the U.S. Food and Drug Administration. the FDA approved BENLYSTA to treat adult patients with acti

By Stephanie Shyu
sshyu@fnno.com

Human Genome Sciences Opens Up 12% After FDA OKs Lupus Treatment

analysis, benlysta, business, financial, glaxosmithkline, gsk, hgsi, human genome sciences, lupus, market, news, stock, trading

Human Genome Sciences (HGSI) is up 11% at the open after it and GlaxoSmithKline (GSK) said the U.S. Food and Drug Administration (FDA) approved BENLYSTA, a drug used to treat adult patients with type of lupus who are receiving sta

By FNNO Staff
fnnonline@gmail.com

Morning Market Snapshot: March 10th, 2011

aig, analysis, business, financial, glaxosmithkline, gsk, hgsi, human genome sciences, lsi, market, netapp, news, ntap, rio, rio tinto, stock, trading

Good Morning. It's Thursday, March 10, 2011. At this hour, U.S. equity futures are down. Overseas, the Asian markets declined, while the European markets are lower. Rio Tinto (RIO) raises bid for Riversdale Mining to A$16.50

By FNNO Staff
fnnonline@gmail.com

Latest News from FNNO

Shares of YRC Worldwide Have Risen Above...

Shares of YRC Worldwide (NASDAQ:YRCW) traded at a new 52-week high today of $30.49. Th ...

Watch for Continued Gains in Shares of T...

Shares of TRW Automotive (NYSE:TRW) traded at a new 52-week high today of $66.79. Appr ...

Shares of Sierra Wireless Rise Above Pre...

Sierra Wireless (NASDAQ:SWIR) traded at a new 52-week high today of $13.03. This new h ...

Seagate Technology: 52-Week High Recentl...

Shares of Seagate Technology (NASDAQ:STX) traded at a new 52-week high today of $45.50. ...

Reinsurance Group of America: The Winnin...

Reinsurance Group of America (NYSE:RGA) traded today at a new 52-week high of $69.15. ...

Targa Resources Partners: 52-Week High R...

Shares of Targa Resources Partners (NASDAQ:NGLS) traded at a new 52-week high today of ...

Recent 52-Week High Exceeded in Shares o...

Shares of Hospira (NYSE:HSP) traded today at $38.50, breaking its 52-week high. Approx ...

Shares of Heartland Payment Systems Rise...

Heartland Payment Systems (NYSE:HPY) traded today at a new 52-week high of $37.17. So ...

Most Popular Video News